Sign in
4

Changes in Ownership

Viking Therapeutics, Inc. Filed Acc 0001209191-24-001973

Director sold 30,000 shares at $23.05 ($691,500)

  • Director acquired 30,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Rouan Sarah Kathryn · Director

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-01-19 Exercise or conversion : show line 1 in the form 10b5-1 +30,000 $8.32 $249,600 30,000 D
2024-01-19 Sale : show line 2 in the form 10b5-1 −30,000 $23.05 $691,500 0 D
Open-market sales · 30,000 sh · avg $23.05 · $691,500

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-01-19 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (Right to Buy) −30,000 25,000 D
Loading xslF345X05/doc4.xml…